{"id":43228,"date":"2025-10-14T13:54:03","date_gmt":"2025-10-14T05:54:03","guid":{"rendered":"https:\/\/flcube.com\/?p=43228"},"modified":"2025-10-14T13:54:04","modified_gmt":"2025-10-14T05:54:04","slug":"boehringer-ingelheim-launches-trajenta-production-in-zhangjiang-china","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=43228","title":{"rendered":"Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China"},"content":{"rendered":"\n<p><strong>Boehringer\u202fIngelheim<\/strong> (BI) announced today the official start\u2011up of its local manufacturing plan for the diabetes medication <strong>Trajenta\u00ae (linagliptin)<\/strong> at its human pharmaceutical production facility in <strong>Zhangjiang, Pudong<\/strong>. The move marks a pivotal shift from commercial operations to vertical integration of the company\u2019s supply chain in the Chinese market.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-highlights\">Key Highlights<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Product<\/strong><\/td><td>Trajenta\u00ae (linagliptin)<\/td><\/tr><tr><td><strong>Facility<\/strong><\/td><td>Zhangjiang, Pudong, Shanghai<\/td><\/tr><tr><td><strong>Strategic Goal<\/strong><\/td><td>Deepen Boehringer\u2019s footprint in China via local production<\/td><\/tr><tr><td><strong>R&amp;D Commitment<\/strong><\/td><td>&gt;\u202fRMB\u202f5\u202fbillion over the next 5\u202fyears<\/td><\/tr><tr><td><strong>\u201cChina\u202fKey\u201d Strategy<\/strong><\/td><td>Pursue earlier or simultaneous approvals for new products\/indications in China versus the global market<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-why-it-matters\">Why It Matters<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Supply Chain Resilience<\/strong> \u2013 Local manufacturing reduces dependence on imports, ensuring timely availability for China\u2019s 1.4\u202fbillion population and the country\u2019s growing diabetes market.<\/li>\n\n\n\n<li><strong>Cost &amp; Pricing Advantage<\/strong> \u2013 Domestic production can lower manufacturing costs and enable more competitive pricing, addressing affordability concerns in China\u2019s tier\u20112 and tier\u20113 cities.<\/li>\n\n\n\n<li><strong>Accelerated Innovation<\/strong> \u2013 The 5\u202fbillion\u202fRMB R&amp;D investment will fuel clinical development of next\u2011generation antidiabetic agents and expanded indications, reinforcing Boehringer\u2019s \u201cChina\u202fKey\u201d pipeline acceleration.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-looking-ahead\">Looking Ahead<\/h2>\n\n\n\n<p>Boehringer\u202fIngelheim plans to leverage its Zhangjiang facility to support both current and future product launches, positioning the company to secure approval for new indications in China ahead of or concurrently with global markets. The strategy underscores the firm\u2019s commitment to the Chinese market as a critical growth engine in the coming decade.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-about-boehringer-ingelheim\">About Boehringer\u202fIngelheim<\/h2>\n\n\n\n<p>Boehringer\u202fIngelheim is a global, research\u2011driven biopharmaceutical company headquartered in Ingelheim am Rhein, Germany. The company focuses on innovative therapies in cardiometabolic diseases, respiratory disorders, and oncology, among other therapeutic areas.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boehringer\u202fIngelheim (BI) announced today the official start\u2011up of its local manufacturing plan for the diabetes&#8230;<\/p>\n","protected":false},"author":1,"featured_media":43230,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,11],"tags":[],"class_list":["post-43228","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-drug"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Boehringer\u202fIngelheim (BI) announced today the official start\u2011up of its local manufacturing plan for the diabetes medication Trajenta\u00ae (linagliptin) at its human pharmaceutical production facility in Zhangjiang, Pudong. The move marks a pivotal shift from commercial operations to vertical integration of the company\u2019s supply chain in the Chinese market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=43228\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=43228\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-14T05:54:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-14T05:54:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1401.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43228#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43228\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China\",\"datePublished\":\"2025-10-14T05:54:03+00:00\",\"dateModified\":\"2025-10-14T05:54:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43228\"},\"wordCount\":285,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43228#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1401.webp\",\"articleSection\":[\"Company\",\"Deals\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43228#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43228\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=43228\",\"name\":\"Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43228#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43228#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1401.webp\",\"datePublished\":\"2025-10-14T05:54:03+00:00\",\"dateModified\":\"2025-10-14T05:54:04+00:00\",\"description\":\"Boehringer\u202fIngelheim (BI) announced today the official start\u2011up of its local manufacturing plan for the diabetes medication Trajenta\u00ae (linagliptin) at its human pharmaceutical production facility in Zhangjiang, Pudong. The move marks a pivotal shift from commercial operations to vertical integration of the company\u2019s supply chain in the Chinese market.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43228#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43228\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43228#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1401.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/1401.webp\",\"width\":1080,\"height\":608,\"caption\":\"Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43228#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China - Insight, China&#039;s Pharmaceutical Industry","description":"Boehringer\u202fIngelheim (BI) announced today the official start\u2011up of its local manufacturing plan for the diabetes medication Trajenta\u00ae (linagliptin) at its human pharmaceutical production facility in Zhangjiang, Pudong. The move marks a pivotal shift from commercial operations to vertical integration of the company\u2019s supply chain in the Chinese market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=43228","og_locale":"en_US","og_type":"article","og_title":"Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=43228","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-14T05:54:03+00:00","article_modified_time":"2025-10-14T05:54:04+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1401.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=43228#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=43228"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China","datePublished":"2025-10-14T05:54:03+00:00","dateModified":"2025-10-14T05:54:04+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=43228"},"wordCount":285,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=43228#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1401.webp","articleSection":["Company","Deals","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=43228#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=43228","url":"https:\/\/flcube.com\/?p=43228","name":"Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=43228#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=43228#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1401.webp","datePublished":"2025-10-14T05:54:03+00:00","dateModified":"2025-10-14T05:54:04+00:00","description":"Boehringer\u202fIngelheim (BI) announced today the official start\u2011up of its local manufacturing plan for the diabetes medication Trajenta\u00ae (linagliptin) at its human pharmaceutical production facility in Zhangjiang, Pudong. The move marks a pivotal shift from commercial operations to vertical integration of the company\u2019s supply chain in the Chinese market.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=43228#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=43228"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=43228#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1401.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1401.webp","width":1080,"height":608,"caption":"Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=43228#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Boehringer\u202fIngelheim Launches Trajenta Production in Zhangjiang, China"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/1401.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43228","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43228"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43228\/revisions"}],"predecessor-version":[{"id":43231,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43228\/revisions\/43231"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/43230"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43228"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43228"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}